Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL

Healthcare Drug Manufacturers - Specialty & Generic
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:CRDL)

Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart

Newsfile 5 days ago

Cardiol Therapeutics Announces Year-End 2025 Update on Operations

Newsfile April 1, 2026

Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference

Newsfile February 25, 2026

Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure

Newsfile February 10, 2026

Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million

Newsfile January 23, 2026

Canadian Investment Regulatory Organization Trade Resumption - CRDL

Canada NewsWire January 16, 2026

Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

Newsfile January 16, 2026

Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million

Newsfile January 16, 2026

Canadian Investment Regulatory Organization Trading Halt - CRDL

Canada NewsWire January 16, 2026
View More News ››

Opinion & Analysis (TSX:CRDL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:CRDL)

New here!

Why the recent run up with no news? Thanks.
Alim33 - April 1, 2026

$CRDL big news - presenting Phase 2 data this month

https://finance.yahoo.com/news/cardiol-therapeutics-phase-ii-archer-124500090.html
stockman691 - November 6, 2025

$CRDL (Nasdaq: $CRDL) $CRDL.TSX #CardiolRx Update out!

$CRDL  (Nasdaq: $CRDL) $CRDL.TSX  #CardiolRx :  “As recruitment in our pivotal Phase III MAVERIC trial gains momentum,...
MasterJediJazz2 - October 30, 2025

$CRDL new article this AM

Nice to see $CRDL recognized along with along with TNYA, VERV as 3 Emerging Leaders in Cardiovascular Innovation: https://allcapresearch...
stockman691 - October 28, 2025

$CRDL CardiolRX Advances After Encouraging Trial Data

$CRDL Nice article out: Cardiol Therapeutics Advances After Encouraging Trial Data https://allcapresearch.com/f/cardiol-therapeutics...
MasterJediJazz2 - October 27, 2025

Due Dilligence

Having technology like the internet that never forgets, there is no reason not to do proper research before investing. 
kidderpeabody - August 23, 2025
View more Bullboard ››

Birchtech Corp.

Birchtech Corp.

Birchtech Corp., an environmental services and technology company, engages in developing and delivering solutions to the ...
View More »

Podcasts